Drugmaker GSK fined in China graft probe: report

A Chinese court on Friday fined British drugmaker GlaxoSmithKline 3.0 billion yuan following a nearly year-long bribery probe, state media said. The...



via The Standard - Breaking News http://ift.tt/1tuwEsO